Pseudowasting syndrome and carcinogenesis after 20-methylcholanthrene administration and effects of Mycobacterium Calmette-Guérin (BCG) in newborn and young mice
Zschiesche, W.; Schulz, W.D.
Zeitschrift für Krebsforschung 75(4): 277-287
1971
ISSN/ISBN: 0301-1585 PMID: 4256493 Document Number: 41788
Document emailed within 1 workday
Related Documents
Bruley-Rosset, M.; Florentin, I.; Kiger, N.; Davigny, M.; Mathé, G. 1978: Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice Cancer Treatment Reports 62(11): 1641-1650Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615
Valdespino Gómez, J.L. 1997: Update topic: the uses and effects of the Calmette-Guérin Mycobacterium bovis bacillus (BCG vaccine) Salud Publica de Mexico 39(2): 93-94
Pedrazzini, T.; Hug, K.; Louis, J.A. 1987: Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo Journal of Immunology 139(6): 2032-2037
Houchens, D.P.; Goldberg, A.I.; Gaston, M.R.; Kende, M.; Goldin, A. 1973: Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice Cancer Research 33(4): 685-690
Cauwels, A.; Fiers, W.; Brouckaert, P. 1996: Murine IL-12 is involved in Calmette-Guérin bacillus-induced sensitization and is by itself sufficient to sensitize mice to the lethal effects of human TNF1 Journal of Immunology 156(12): 4686-4690
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
Lin, C.J.; Yang, W.S.; Yan, J.J.; Liu, C.C. 1999: Mycobacterium bovis osteomyelitis as a complication of Bacille Calmette-Guérin (BCG) vaccination: rapid diagnosis with use of DNA sequencing analysis: a case report Journal of Bone and Joint Surgery. American Volume 81(9): 1305-1311
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405
Silver, R.F.; Wallis, R.S.; Ellner, J.J. 1995: Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals Journal of Immunology 154(9): 4665-4674
Vogl, S.E.; Lumb, G.; Bekesi, J.G.; Holland, J.F. 1977: Preclinical study of iv administration of the methanol extraction residue of bacillus Calmette-Guérin Cancer Treatment Reports 61(5): 901-903
Méndez-Samperio, P.; Pérez, A.; Trejo, A. 2007: Sphingosine kinase, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 are required for CCL5 production in Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-infected epithelial cells Cellular Immunology 249(2): 94-100
Ryder, R.W.; Oxtoby, M.J.; Mvula, M.; Batter, V.; Baende, E.; Nsa, W.; Davachi, F.; Hassig, S.; Onorato, I.; Deforest, A. 1993: Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1 Journal of Pediatrics 122(5 Part 1): 697-702
Dunkley-Thompson, J.; Pierre, R.B.; Steel-Duncan, J.; Palmer, P.; Davis, D.; Figueroa, J.P.; Christie, C.D.C. 2008: Bacille Calmette-Guérin lymphadenitis and immune reconstitution syndrome in HIV-infected children on antiretroviral therapy in Jamaica West Indian Medical Journal 57(3): 302-306
Tanooka, H.; Arimoto, H. 1984: Radioisotope-decay model of carcinogenesis: multistep process in the formation of original single tumor cells induced by 3-methylcholanthrene in mice Gan 75(2): 126-129
Argus, M.F.; Hoch-Ligeti, C.; Arcos, J.C. 1982: Comparative pulmonary tumorigenesis in DBA/2J and C57Bl/6J mice by administration of 3-methylcholanthrene and dimethylnitrosamine singly and combined Neoplasma 29(5): 527-534
Anderson, L.M.; Seetharam, S. 1985: Protection against tumorigenesis by 3-methylcholanthrene in mice by beta-naphthoflavone as a function of inducibility of methylcholanthrene metabolism Cancer Research 45(12 Part 1): 6384-6389
Goupille, P.; Valat, J.P. 1996: Arthritis after bacillus Calmette-Guérin therapy Journal of Rheumatology 23(8): 1481-1482
Freedman, S.O. 1979: Bacille Calmette--Guérin in cancer...therapy? Canadian Medical Association Journal 121(1): 13
Merrin, C.; Han, T.; Klein, E.; Wajsman, Z.; Murphy, G.P. 1975: Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin Cancer ChemoTherapy Reports 59(1): 157-163